alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
registrant's financial statements contained in its Quarterly Report on Form 10-Q
for the period ended September 30, 1995 and is qualified in its entirety by
reference to such financial statements.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                           1,746
<SECURITIES>                                         0
<RECEIVABLES>                                  112,094
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               113,840
<PP&E>                                      13,107,922
<DEPRECIATION>                              10,232,380
<TOTAL-ASSETS>                               2,989,382
<CURRENT-LIABILITIES>                          482,788
<BONDS>                                              0
<COMMON>                                             0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                   2,361,480
<TOTAL-LIABILITY-AND-EQUITY>                 2,989,382
<SALES>                                        536,527
<TOTAL-REVENUES>                               544,076
<CGS>                                                0
<TOTAL-COSTS>                                  984,376<F1>
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              30,492
<INCOME-PRETAX>                              (535,888)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (535,888)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (535,888)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
<FN>
<F1>Includes lease operating expense, production taxes, and depreciation, depletion
and amortization expense.
</FN>
        

</TABLE>
I 

118TH CONGRESS 

2D SESSION H. R. 7705 

To amend the Internal Revenue Code of 1986 to expand the credit for 

expenditures to provide access to disabled individuals. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 15, 2024 

Mr. MOLINARO (for himself and Ms. CROCKETT) introduced the following bill; 

which was referred to the Committee on Ways and Means 

A BILL 

To amend the Internal Revenue Code of 1986 to expand 

the credit for expenditures to provide access to disabled 

individuals. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Think DIF5 FERENTLY Small Business Accessibility Act’’. 

6 SEC. 2. EXPANDED CREDIT FOR EXPENDITURES TO PRO7 VIDE ACCESS TO DISABLED INDIVIDUALS. 

8 (a) IN GENERAL.—Section 44(b)(1) of the Internal 

9 Revenue Code of 1986 is amended— 


rfrederick on LAP8M3WLY3PROD with BILLS
2 

•HR 7705 IH

1 (1) in subparagraph (A), by striking 

2 ‘‘$1,000,000’’ and inserting ‘‘$3,500,000’’, and 

3 (2) in subparagraph (B), by striking ‘‘30 full4 time employees’’ and inserting ‘‘100 full-time em5 ployees’’. 

6 (b) EFFECTIVE DATE.—The amendments made by 

7 this section shall apply to taxable years beginning after 

8 December 31, 2023. 

Æ 


rfrederick on LAP8M3WLY3PROD with BILLS
Exhibit 32.2

STATEMENT OF CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the Form 10-Q of Hilb Rogal & Hobbs Company for the quarter ended September 30, 2007, I, Michael Dinkins, Executive Vice
President and Chief Financial Officer of Hilb Rogal & Hobbs Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(a) such Form 10-Q for the quarter ended September 30, 2007 fully complies with the requirements of section 13(a) of the Securities Exchange Act of
1934, as amended; and

(b) the information contained in such Form 10-Q for the quarter ended September 30, 2007 fairly presents, in
all material respects, the consolidated financial condition and results of operations of Hilb Rogal & Hobbs Company and its subsidiaries as of and for the periods presented in such Form 10-Q.



| |  |     |  |                                                      |  |  |  |       |  |                 
| |  | --- |  | ---------------------------------------------------- |  |  |  | ----- |  | ----------------
| |  | By: |  | /s/ Michael Dinkins                                  |  |  |  | Date: |  | November 1, 2007
| |  |     |  | Michael Dinkins                                      |  |  |  |       |  |                 
| |  |     |  | Executive Vice President and Chief Financial Officer |  |  |  |       |  |
Editorial Note on Part 866
Editorial Note: Nomenclature changes to part 866 appear at 73 FR 35341, June 23, 2008.

§ 866.5250 Complement C1 inhibitor (inactivator) immunological test system. ( a ) *Identification.* A complement C1 inhibitor (inactivator) immunological test system is a device that consists of the reagents used to measure by immunochemical techniques the complement C1 inhibitor (a plasma protein) in serum. Complement C1 inhibitor occurs normally in plasma and blocks the action of the C1 component of complement (a group of serum proteins which destroy infectious agents). Measurement of complement C1 inhibitor aids in the diagnosis of hereditary angioneurotic edema (increased blood vessel permeability causing swelling of tissues) and a rare form of angioedema associated with lymphoma (lymph node cancer).
( b ) *Classification.* Class II (performance standards).
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

January 29, 2007 Clifford W. Taylor, Chief Justice
132378 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 132378 COA: 263091 Mecosta CC: 04-005368-FC CHRISTOPHER ANDREW FOSTER, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application fo r leave to appeal th e October 17, 2006 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

p0122 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

January 29, 2007

Clerk
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.1760 Volume plethysmograph. ( a ) *Identification.* A volume plethysmograph is an airtight box, in which a patient sits, that is used to determine the patient's lung volume changes.
( b ) *Classification.* Class II (performance standards).
Exhibit 10.17

             Amendment No. 4 to Omega Employee Stock Ownership Plan

                           OMEGA FINANCIAL CORPORATION

                          EMPLOYEE STOCK OWNERSHIP PLAN

                      (Restated, Effective January 1, 1997)

                                 AMENDMENT NO. 4

      Omega Financial Corporation, a Pennsylvania corporation (the "Employer"),
hereby adopts this amendment to the Omega Financial Corporation Employee Stock
Ownership Plan ("Plan"). This amendment is adopted pursuant to Section 17.01 of
the Plan.

      1. Section 7.05(c) of the Plan is hereby amended to read as follows:

            "(c) Portion of Account Subject to Diversification. An election by a
      Participant to diversify the investments in his/her Company Stock
      Subaccount pursuant to this Section shall not exceed the number of shares
      determined by multiplying the number of shares of Company Stock allocated
      to such Participant's Company Stock Subaccount (including shares of
      Company Stock the value of which has been previously diversified pursuant
      to this Section), by 25% or, with respect to the last Plan Year in the
      Qualified Election Period, 50%, reduced by the number of shares of Company
      Stock of any prior diversification made pursuant to this Section.
      Notwithstanding the preceding sentence to the contrary, during the ninety
      days following the end of each Plan Year after the Qualified Election
      Period, a Participant may elect to diversify the investments in his/her
      Company Stock Subaccount provided that the diversification shall not
      exceed the number of shares determined by multiplying the number of shares
      of Company Stock allocated to such Participant's Company Stock Subaccount
      (including shares of Company Stock the value of which has been previously
      diversified pursuant to this Section), by 50%, reduced by the number of
      shares of Company Stock of any prior diversification made pursuant to this
      Section. The diversification election provided in the preceding sentence
      shall not be available to a Participant if such election would cause the
      Plan to violate the requirements of Section 401(a) of the Code."

      2. This amendment shall be effective as of January 1, 2003.


                                       41
<PAGE>

      IN WITNESS WHEREOF, and as evidence of the adoption of this amendment, the
Employer has caused the same to be executed and attested by its duly authorized
officers this 27th day of January, 2003.

ATTEST:                                     OMEGA FINANCIAL CORPORATION


         /s/ David N. Thiel                 By: /s/ David B. Lee
              Secretary                     Title: Chairman and CEO


                                       42
Editorial Note on Part 882
Editorial Note: Nomenclature changes to part 882 appear at 73 FR 35341, June 23, 2008.

§ 882.1890 Evoked response photic stimulator. ( a ) *Identification.* An evoked response photic stimulator is a device used to generate and display a shifting pattern or to apply a brief light stimulus to a patient's eye for use in evoked response measurements or for electroencephalogram (EEG) activation.
( b ) *Classification.* Class II (performance standards).
CMP-5 

Revised: May 10, 2004

San Joaquin Valley Air Pollution Control District 

Supplemental Application Form 

Conservation Management Practices: DRY BEANS, CEREAL 

GRAINS, SAFFLOWER, 

WHEAT, AND BARLEY 

Farm Name: CMP Plan Years: to 

Maximum Crop Acreage: 

Fallow Acreage Last Planted in Dry Beans, Cereal Grains, Safflower, Wheat, or Barley: 

Land 

Preparation/ 

Cultivation 

Select at least one of the following CMPs. 

Note: 100% of the maximum crop acreage must be covered by the selected CMPs. 

 Bed/Row Size or Spacing, ac Mulching, ac 

 Chemigation/Fertigation, ac Multiple CMPs in Another Category 

 Combined Operations, ac Night Farming, ac 

 Conservation Irrigation, ac Precision Farming (GPS), ac 

 Conservation Tillage, ac Transgenic Crops, ac 

 Equipment Change/Tech. Improvements, _____ ac Other (approved on a case-by-case basis), ac 

Please describe the specifics of the practice(s) chosen above: 

 

 

 

Harvest 

Select at least one of the following CMPs. 

Note: 100% of the maximum crop acreage must be covered by the selected CMPs. 

 Baling/Large Balers, ac Multiple CMPs in Another Category 

 Combined Operations, ac Night Harvesting, ac 

 Equipment Change/Tech. Improvements, ac Shuttle System, ac 

 Green Chop, _____ ac Other (approved on a case-by-case basis), ac 

Please describe the specifics of the practice(s) chosen above: 

 

 

 

Other 

Select at least one of the following CMPs. 

Note: 100% of the maximum crop acreage must be covered by the selected CMPs. 

 Application Efficiencies, ac Mulching, ac 

 Baling/Large Balers (crop residue), ac No Burning, ac 

 Bulk Materials Control Surface Roughening, ac 

 Multiple CMPs in Another Category Transgenic Crops, ac 

 Conservation Irrigation, ac Wind Barrier, ac 

 Integrated Pest Management (IPM), ac Other (approved on a case-by-case basis), ac 

 Irrigation Power Units 

Please describe the specifics of the practice(s) chosen above: 

 

 

 

CMP

5
§ 876.5330 Transcutaneous electrical continence device. ( a ) *Identification.* A transcutaneous electrical continence device consists of cutaneous electrodes that are used to apply external stimulation to reduce urinary incontinence.
( b ) *Classification.* Class II (special controls). The special controls for this device are: ( 1 ) Non-clinical performance testing must characterize the electrical stimulation, including the following: Waveforms, output modes, maximum output voltage, maximum output current, pulse duration, frequency, net charge per pulse, maximum phase charge at 500 ohms, maximum current density, maximum average current, and maximum average power density.
( 2 ) The patient-contacting materials must be demonstrated to be biocompatible.
( 3 ) Performance data must demonstrate the electromagnetic compatibility (EMC), electrical safety, thermal safety, and mechanical safety of the device.
( 4 ) Software verification, validation, and hazard analysis must be performed.
( 5 ) Labeling must include the following: ( i ) Instructions for use, including specific instructions regarding the proper placement of electrodes;
( ii ) A summary of electrical stimulation parameters; and
( iii ) Cleaning instructions and reuse information.
[86 FR 73971, Dec. 29, 2021]
* Local Rule 47.5 provides: "The publication of opinions

that have no precedential value and merely decide particular

cases on the basis of well-settled principles of law imposes

needless expense on the public and burdens on the legal

profession." Pursuant to that Rule, the court has determined

that this opinion should not be published.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

__________________

No. 95-10357 

Conference Calendar

__________________

EDGAR LEE DEARS,

 Plaintiff-Appellant,

versus

HORACE SCOTT, Parole Supervisor;

CHARLES MARTIN, Hearing Officer,

 Defendants-Appellees.

- - - - - - - - - -

Appeal from the United States District Court

for the Northern District of Texas

USDC No. 4:95-CV-209-Y

- - - - - - - - - -

August 24, 1995

Before KING, JOLLY, and WIENER, Circuit Judges.

PER CURIAM:*

Edgar Lee Dears challenges the dismissal of his civil rights

complaint. A complaint filed in forma pauperis may be dismissed

as frivolous if it lacks an arguable basis in fact or law. A

§ 1915(d) dismissal is reviewed for abuse of discretion. Ancar

v. Sara Plasma, Inc., 964 F.2d 465, 468 (5th Cir. 1992). 
No. 95-10357

-2-

Claims alleging "harm caused by actions whose unlawfulness

would render a conviction or sentence invalid" cannot be brought

under § 1983 unless that "conviction or sentence has been

reversed on direct appeal, expunged by executive order, declared

invalid by a state tribunal authorized to make such

determination, or called into question by a federal court's

issuance of a writ of habeas corpus, 28 U.S.C. § 2254." Heck v.

Humphrey, 114 S. Ct. 2364, 2372 (1994). Heck applies to

proceedings which call into question the fact or duration of

parole. Jackson v. Vannoy, 49 F.3d 175, 177 (5th Cir. 1995),

petition for cert. filed (U.S. May 15, 1995) (No. 94-9704). When

a claim may be dismissed on the ground of absolute immunity, that

route should be taken without considering a Heck dismissal. Boyd

v. Biggers, 31 F.3d 279, 284 (5th Cir. 1994).

Dears does not allege that his sentence or any revocation

proceeding has been reversed, expunged, or set aside by a state

court, or called into question by a federal court's issuance of a

writ of habeas corpus. Moreover, Martin's participation in the

quasi-judicial activity of revoking parole afforded him absolute

immunity from damages. See Walter v. Torres, 917 F.2d 1379, 1383

(5th Cir. 1990). Therefore, the district court did not abuse its

discretion when it dismissed his complaint.

AFFIRMED.
<TABLE> <S> <C>

<PAGE>
<ARTICLE>          5
<PERIOD-TYPE>                                    3-MOS
<FISCAL-YEAR-END>                          MAR-31-2001
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          25,853
<SECURITIES>                                         0
<RECEIVABLES>                                  195,684
<ALLOWANCES>                                         0
<INVENTORY>                                     93,678
<CURRENT-ASSETS>                               353,154
<PP&E>                                         458,712
<DEPRECIATION>                               (147,687)
<TOTAL-ASSETS>                                 872,257
<CURRENT-LIABILITIES>                          137,055
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       197,829
<OTHER-SE>                                     223,726
<TOTAL-LIABILITY-AND-EQUITY>                   872,257
<SALES>                                        183,813
<TOTAL-REVENUES>                               183,813
<CGS>                                          105,604
<TOTAL-COSTS>                                  105,604
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,481
<INCOME-PRETAX>                                  1,335
<INCOME-TAX>                                       507
<INCOME-CONTINUING>                                828
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       828
<EPS-BASIC>                                       0.01
<EPS-DILUTED>                                     0.01

</TABLE>
U.S. GOVERNMENT PUBLISHING OFFICE

WASHINGTON : 

1 

89–012 2019

116th Congress, 1st Session – – – – – – – – – – – – – House Document 116–38 

DESIGNATION OF FUNDING AS AN EMERGENCY 

REQUIREMENT 

COMMUNICATION 

FROM

THE PRESIDENT OF THE UNITED STATES 

TRANSMITTING

DESIGNATION OF FUNDING AS AN EMERGENCY REQUIREMENT, 

PURSUANT TO ADDITIONAL SUPPLEMENTAL APPROPRIATIONS 

FOR DISASTER RELIEF ACT, 2019, SECTION 1204 

JUNE 10, 2019.—Referred to the Committee on Appropriations and ordered 

to be printed 


lotter on DSKBCFDHB2PROD with REPORTSE:\Seals\Congress.#13

lotter on DSKBCFDHB2PROD with REPORTS
(1) 

THE WHITE HOUSE, 

Washington, June 6, 2019. 

Hon. NANCY P. PELOSI, 

Speaker of the House of Representatives, 

Washington, DC. 

DEAR MADAM SPEAKER: In accordance with section 1204 of the 

Additional Supplemental Appropriations for Disaster Relief Act, 

2019 (H.R. 2157; the ‘‘Act’’), I hereby designate as emergency requirements all funding (including the transfer of funds) so designated by the Congress in the Act pursuant to section 251(b)(2)(A) 

of the Balanced Budget and Emergency Deficit Control Act of 1985, 

as outlined in the enclosed list of accounts. 

The details of this action are set forth in the enclosed memorandum from the Acting Director of the Office of Management and 

Budget. 

Sincerely, 

DONALD J. TRUMP. 


lotter on DSKBCFDHB2PROD with REPORTS
2 


lotter on DSKBCFDHB2PROD with REPORTSInsert offset folio 3 here HD38.001
3 


lotter on DSKBCFDHB2PROD with REPORTSInsert offset folio 4 here HD38.002
4 


lotter on DSKBCFDHB2PROD with REPORTSInsert offset folio 5 here HD38.003
5 


lotter on DSKBCFDHB2PROD with REPORTSInsert offset folio 6 here HD38.004
6 


lotter on DSKBCFDHB2PROD with REPORTSInsert offset folio 7 here HD38.005
7 


lotter on DSKBCFDHB2PROD with REPORTSInsert offset folio 8 here HD38.006
§ 522.723 Diprenorphine. ( a ) *Specifications.* Each milliliter of solution contains 2 milligrams of diprenorphine hydrochloride.
( b ) *Sponsors.* See No. 053923 in § 510.600(c) of this chapter.
( c ) *Conditions of use* — ( 1 ) *Amount.* It is administered intramuscularly or intravenously at a suitable dosage level depending upon the species.
( 2 ) *Indications for use.* The drug is used for reversing the effects of etorphine hydrochloride injection, veterinary, the use of which is provided for in § 522.883, in wild and exotic animals.
( 3 ) *Limitations.* For use in wild or exotic animals only. Do not use in domestic food-producing animals. Do not use 30 days before, or during, the hunting season in free-ranging wild animals that might be used for food. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Distribution is restricted to veterinarians engaged in zoo and exotic animal practice, wildlife management programs, and researchers.
[79 FR 16187, Mar. 25, 2014]
<PAGE>

                                                                   EXHIBIT 10.38

                        (Venture Finance PLC letterhead)

Date

PRIVATE & CONFIDENTIAL
The Directors
Xcel Power Systems Limited
Brunswick Road
Cobbs Wood
Ashford
Kent     TN23 1EB

Dear Sirs:

We refer to the Agreement for the Purchase of Debts between Xcel Power Systems
Limited and Venture Finance PLC, which commenced on 12 November 2002 and advise
you of the following amendments to the Schedule to the Agreement for the
Purchase of Debts.

Condition for Deletion:

18       Special Conditions:

         5.       Prior to Venture making any Prepayment subordination of all
                  loans to the Group from Microtel International Inc. will be
                  required by Venture

Conditions to be amended as shown:

         (i) Currency              Pounds Sterling, US Dollars and Euros (clause
         18(3)(ii)(a):

18       Special Conditions:

         7.       Prior to making any Prepayment, Venture will require a Deed of
                  Postponement in respect of the indebtedness of (pound)200,000
                  (Pounds Sterling Two Hundred Thousand) due from Xcel
                  Corporation Limited to Microtel International Inc.

Please sign and return the attached copy of this letter as acceptance of the
amendments to the Schedule to the Agreement for the Purchase of Debts between
Xcel Power Systems Limited and Venture Finance PLC.

<TABLE>
<CAPTION>

<S>                                                 <C>
Yours faithfully
For and on behalf of
VENTURE FINANCE PLC                                 Amendments to Terms and Conditions agreed For and on
                                                    behalf of Xcel Power Systems Limited
/S/ PAUL BEVERIDGE
As Attorney for Venture Finance PLC                 Signed /S/ CARMINE T. OLIVA          Date 23-10-02
                                                           -----------------------------      --------

In the presence of

PAUL ARPS                    /S/ PAUL ARPS          Signed /S/ GRAHAM JEFFERIES          Date 23-10-02
---------------------------  ------------------            -----------------------------      --------
</TABLE>